U.S. PHARMACOPEIA

Search USP29  
Aminophylline Delayed-Release Tablets
» Aminophylline Delayed-Release Tablets contain an amount of aminophylline equivalent to not less than 93.0 percent and not more than 107.0 percent of the labeled amount of anhydrous theophylline (C7H8N4O2).
NOTE—The ammoniacal odor present in the vapor space above Aminophylline Delayed-Release Tablets is often quite strong, especially when bottles having suitably tight closures are newly opened. This is due to ethylenediamine vapor pressure build-up, a natural condition in the case of aminophylline.
Packaging and storage— Preserve in tight containers.
Labeling— Label the Tablets to state the content of anhydrous theophylline.
Disintegration 701: 30 minutes, determined as directed under Delayed-Release (enteric coated) Tablets.
Residual solvents 467: meet the requirements.
(Official January 1, 2007)
Other requirements— Tablets respond to the Identification tests and meet the requirements for Uniformity of dosage units, Ethylenediamine content and Assay under Aminophylline Tablets.
Auxiliary Information— Staff Liaison : Daniel K. Bempong, Ph.D., Scientist
Expert Committee : (MDPS05) Monograph Development-Pulmonary and Steroids
USP29–NF24 Page 143
Phone Number : 1-301-816-8143